Exchange: NASDAQ·Updated 08:21 AM EDT

FLNA Filana Therapeutics Inc

$0.7799
$0.0071
(0.92%)
Pre-Market
Prev Close $0.7728
EarningsOct 29
Mkt Cap$37.33M
Vol30,829.00

About FLNA

Filana Therapeutics, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.
77

Extremely Bullish Sentiment

How do you feel about FLNA?

Advertisement|Remove ads.